London, United Kingdom–(Newsfile Corp. – December 15, 2025) – Edison issues report on discoverIE Group (LSE: DSCV).
discoverIE reported solid H126 results, with adjusted EPS growth of 6% on reported revenue growth of 2.5%. Organic revenue growth has resumed at the group level and in three out of the four operating units, and two acquisitions have just been announced. Having managed the group to grow earnings and optimise cash during an 18-month period of organic revenue reduction due to industry-wide customer destocking, the company is well-positioned to benefit as demand recovers, we believe. We see the opportunity for the wide discount to peers to narrow now that the group is back on a top-line growth trajectory.
Click here to read the full report.
All reports published by Edison are available to download free of charge from its website www.edisongroup.com
Edison is authorised and regulated by the Financial Conduct Authority.
Edison is not an adviser or broker-dealer and does not provide investment advice. Edison’s reports are not solicitations to buy or sell any securities.
For more information, please contact Edison:
enquiries@edisongroup.com
+44 (0)20 3077 5700
Connect with Edison on:
LinkedIn www.linkedin.com/company/edison-group-/
X www.x.com/edison_inv_res
YouTube www.youtube.com/edisonitv
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/278038
ST. PAUL, Minn., Dec. 16, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that it…
ValuePenguin finds in 45 states, 2026 Health Insurance Premiums are Increasing by More Than 10%…
In this free webinar, learn about the advantages of leveraging EPQT and AI-powered data quality…
In this free webinar, learn how to identify sources of variability in bioassay method transfers…
In this free webinar, learn how medical devices benefit from modern digital validation strategies. Attendees…
Backed by $14M in seed funding led by Andreessen Horowitz, and pre-seed funding led by…